Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center of Genomic medicine, |
RCV000627042 | SCV000747747 | pathogenic | Nonsyndromic genetic hearing loss | 2017-11-20 | criteria provided, single submitter | clinical testing | This homozygous variant was identified in a female patient with non-syndromic and progressive deafness, due to bilateral vestibulo-cochlear dysfunction. One of her two brothers who is also deaf also harbours this variant in a homozygous state. |
3billion, |
RCV001807772 | SCV002058683 | uncertain significance | Leukoencephalopathy, progressive, infantile-onset, with or without deafness | 2022-01-03 | criteria provided, single submitter | clinical testing | Same nucleotide change resulting in same amino acid change has been previously reported to be associated with KARS1 related disorder (ClinVar ID: VCV000060752, PS1_P). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000028, PM2_M). A missense variant is a common mechanism associated with Leukoencephalopathy (PP2_P).Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. |
OMIM | RCV000054525 | SCV000083003 | pathogenic | Autosomal recessive nonsyndromic hearing loss 89 | 2013-07-11 | no assertion criteria provided | literature only | |
Department of Molecular and Human Genetics, |
RCV000054525 | SCV000249614 | pathogenic | Autosomal recessive nonsyndromic hearing loss 89 | 2014-01-17 | no assertion criteria provided | research |